Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2013 by Stanford University.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
David Miklos, Stanford University
ClinicalTrials.gov Identifier:
NCT01155817
First received: June 15, 2010
Last updated: May 5, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2014
  Estimated Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)